Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Colorectal Neoplasms 2 Recurrence 1 Polycystic Ovary Syndrome 1 Obesity 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Intraocular Lymphoma 1 Inflammation 1 Hodgkin Disease 1 Frailty 1 Corneal Endothelial Cell Loss 1 Cataract 1 Breast Neoplasms 1 Anemia 1

Interventions

palbociclib 1 microcrystalline cellulose 1 epigallocatechin gallate 1 dapagliflozin 1 Vitamin D 1 Tablets 1 Specimen Handling 1 Selenium 1 Saline Solution 1 Pregabalin 1 Platelet Count 1 Plastic Surgery Procedures 1 Omeprazole 1 Losartan 1 Ketorolac 1 Infliximab 1 Immunotherapy, Adoptive 1 Dexmedetomidine 1 Cognitive Behavioral Therapy 1 Calcium 1 Bevacizumab 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Inflammation × Ascorbic Acid × Clear all

NCT06068543 2026-03-06

ReFOCUS2

University of Rochester

Phase 2 Recruiting

Frailty, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡